 |
Speakers
Neal L. Eigler, MD
Senior Vice President
CRMD Technology Incubation
St. Jude Medical
Dr. Eigler received a B.S. in cybernetic engineering from UCLA in 1974 and M.D. from Yale University School of Medicine in 1978. His post graduate training included Internal Medicine Residency, Chief Residency, and Fellowship in Cardiology at Cedars-Sinai Medical Center from 1978-85. Dr. Eigler was the Co-Director of the Cardiac Catheterization Laboratory at CSMC from 1985 to 2004 and became Professor of Medicine at UCLA in 1997.
In addition to clinical practice, he has over 30 year of biomedical device research experience focusing on interventional cardiology and academically has authored more than 120 full-length peer-reviewed publications. He has participated in the development and early clinical testing of a multitude of cardiovascular devices, including digital cardiovascular X-ray and ultrasonic imaging, excimer laser coronary angioplasty, PTCA balloons, stents, local coronary drug delivery systems, intravascular radiation therapy systems, and implantable heart failure monitoring systems. He has 14 issued and 41 published/ pending US patents.
Dr Eigler has worked with early stage medical device companies since 1988. He was a Co-founder and Director of Progressive Angioplasty Systems, a company that developed, manufactured, and marketed angioplasty balloons, coronary stents and brachytherapy systems. PAS was acquired by US Surgical Corporation in 1997. Dr Eigler participated in the early stages of Conor Medsystems as an inventor, investor, and Medical Director. Conor, which manufactures second generation drug eluting stents, went public in late 2004 and was acquired by Johnson and Johnson in early 2007.
Starting in 2000, Dr Eigler co-founded Savacor, Inc. and served as it's only CEO. Savacor developed implantable left atrial pressure monitoring technology for treating patients with chronic heart failure. Since Savacor was acquired by St Jude Medical at the end of 2005 he has remained to manage the clinical development and commercialization of implantable systems for treating heart failure. |
 |
|
 |